| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 38.210 | 38.239 | - | 60.458 | 63.757 | 63.698 | 77.363 | 97.567 |
| Total Income - EUR | - | - | 38.210 | 38.239 | - | 60.458 | 63.757 | 63.698 | 77.363 | 97.607 |
| Total Expenses - EUR | - | - | 23.138 | 20.659 | - | 25.922 | 35.400 | 29.859 | 37.881 | 58.234 |
| Gross Profit/Loss - EUR | - | - | 15.072 | 17.580 | - | 34.537 | 28.357 | 33.840 | 39.483 | 39.373 |
| Net Profit/Loss - EUR | - | - | 14.690 | 17.198 | - | 33.959 | 27.796 | 33.215 | 38.725 | 36.503 |
| Employees | - | - | 2 | 2 | - | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Cavimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 538 | 456 | - | 542 | 893 | 672 | 3.119 | 7.382 |
| Current Assets | - | - | 30.500 | 47.344 | - | 105.989 | 130.956 | 67.614 | 53.274 | 33.571 |
| Inventories | - | - | 341 | 207 | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 6.659 | 13.705 | - | 19.124 | 38.672 | 636 | 37.760 | 2.550 |
| Cash | - | - | 23.500 | 33.432 | - | 86.865 | 92.284 | 66.978 | 15.514 | 31.022 |
| Shareholders Funds | - | - | 30.103 | 46.749 | - | 105.595 | 131.050 | 66.422 | 52.768 | 36.551 |
| Social Capital | - | - | 44 | 43 | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.071 | 1.187 | - | 936 | 800 | 1.864 | 3.625 | 4.576 |
| Income in Advance | - | - | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cavimed S.r.l.